tion of drugs, coupled with the increasing reliance on accurate laboratory data, have led us to develop programs which will automatically warn a physician when test results may be altered due to pharmecuticals. Using a clinical laboratory computer system, software has been developed which checks to determine if the result of any test performed on a patient specimen may be affected by any drug administered to that same patient. If possible interference is detected, a comment is automatically attached to the result on the patient's computer-generated report warning the attending physician the result may be falsely elevated or lowered. These programs are run on a laboratory computer system whose central processing unit is a Control Data Corporation, model 1784, computer with 16-bit words and 256K bytes of central storage. All programs are written in Control Data Corporation FORTRAN IV. There are six related programs ranging in size from 560 to 4400 words requiring a total storage capacity of 12,400 words and three data files requiring a total of 213,600 words of storage. The first three programs provide the user with an alphabetized listing of all laboratory result reporting names and are divided to: i) collect; 2) sort; 3) and print the data. The next program creates a drug/test interference data file which stores information on the effect of a given drug on a variety of laboratory tests. Since patient/drug information may derive from more than one source using different drug code numbers, a program was developed to create or update a data file which serves as a cross-reference index between the laboratory drug number and the pharmacy drug number(s). The final program allows for entry of patient identification and drug data, checks for drug/test interference and, if interference is detected, automatically attaches an appr6priate comment to the result in the patient's file. All of these programs operate in a real-time environment.
INTRODUCTION
For many years there has been increasing concern about the effect which drugs have on clinical laboratory test results (1) (2) (3) (4) . This concern has been accentuated not only by the increasing variety and sensitivity of the analytical procedures, but also by the continued development and administration of more and more drugs. Except for commonly administered drugs, it is difficult for the practicing physician to be aware of all of the interference of these various drugs. To assist in this regard, Young and his colleagues have published an extensive compilation (5) which gives a drug-by-drug and test-by-test listing of all known interference. While this is an excellent reference source, it would be even better if this information were automatically presented to the physician each time possible interference was suspected (6, 7) . This report will describe how a central clinical laboratory computer system has been used to meet this challenge.
FLOWCHARTS, PROGRAHS AND DATA FILES
The design of the software system consists of four distinct, but related, programs.
First, so that each affected test could be assigned to the correct drug, all results with the same reporting methodology were brought together, e.g. the enzyme, alkaline phosphatase, may be reported separately or as an integral part of a profile under a different test code (ALK versus SMAI2*). Second, a data file was created which matches each reporting name to the drug interference data found in the compilation of Young, et.al. (5) . Third, provision was made for the input of different drug codes from more than one source. And fourth, patient and drug-administration information must be entered and, if possible interference is detected, a footnote will be appended to the result warning of this possibility.
Each of these programs is described in more detail below.
2.1 Alphabetized Listin 9 of all Result Reportin 9 Names
Since a large medical center clinical laboratory performs several hundred discrete tests or profiles, the first problem was to find all like tests which were performed similary eyen thqugh they might be reported under different neaalngs by the computer system. The design of our clinical laboratory computer system software is such that the details concerning each test or profile are stored in a standardized data file called the "methodology file" (MF). Each methodology has a section where the one or more reporting names associated with a test code are stored. The first program was designed to collect all reporting names from each methodology, to sort these alphabetically and to list them. Since the tasks fall easily into three distinct operations, the program was broken into three parts: (I) an initial section(TSTLC) to collect the data; (2) a first overlay (TSTLCl) for sorting; and (3) a second overlay (TSTLC2) for printing.
Flowcharts for each are shown in Figure i . No new data files are created by the TSTLC program(s). The listing provides the following information alphabetized by reporting name: reporting name, test index, result number and full test name. The "test index" is needed since each reporting name is stored in the MF file under some index number. The "result number" indicates which number in a profile belongs to the indicated reporting name, e.g. in the "SMA 12" profile" (full test name)"Alkaline Phosphatase" (reporting name) is result number ten of twelve results. And finally, the "full test name" shows whether the reporting name is part of the profile or is a discrete test.
Creation of the Drug/Test Interference Files
This program (INTWRT) creates or updates a data file (DRGTST) which stores information on the effect of a given drug on a variety of laboratory tests. The flowchart for the INTWRT program is shown in Figure 2 . Each drug is assigned a "Laboratory Medicine number" and a direct-access file then is built which is keyed to this number. In building the file, after the Laboratory Medicine drug number and the generic drug name are entered, the information from the TSTLC program and the N.I.H. compilation (5) are used to determine the text index of each test affected by thedrug. Following entry of the index, the result number for the test is entered and an indication of whether the in vitro test result is increased or decreased by the drug. The in vivo physiological effect of the drug on the substance to be measured has not been incorporated into the DRGTST file, although it could be. If it were included in the file, the comment attached to the result should clearly state whether the effect of the drug was in vivo or in vitro.
If no additional tests are affected by a drug, all information stored in the buffer for the drug is displayed for review. Individual corrections for a given test can be made by entry of the index for that test. When all corrections for a given drug are completed, the information in the buffer is written to the appropriate sector of the DRGTST file. Individual sectors of this file can be updated at a subsequent time by specifying the drug number which is used for reading of the appropriate sector of the DRGTST file into the buffer. After any corrections are made, the buffer again is written back to the DRGTST file.
Details of the structure of this file are shown in Table I This program (XDGWRT) creates or updates a data file (XDRGNO) which serves as a crossreference index between the Laboratory Medicine drug numbers and the pharmacy drug numbers. The flowchart for the XDGWRT program is shown in Figure 3 . This file has been included to allow for entry of data from separate pharmacies using different numbering systems. For example, the Medical University Hospital and Family Practice clinic pharmacies use different numbering systems. In the latter case, the program asks for the Family Practice number and then the Laboratory Medicine number. After these have been entered, the program writes the Laboratory Medicine number into that word of the file (offset) equal to the Family Practice number, e.g. if the Family Practice number for acetominophen is 65, the Laboratory Medicine code for this drug would be stored in word 65 of the XDRGNO file.
XDRGNO is a directaccess file, 2400 words in length.
Entry of Patient Data and Drug/Test Interference Check
The function of this program (DRGINT) is to allow for entry of patient identification and drug data, to check for drug/test interference and, if possible interference is detected, to attach an appropriate comment to the result in the patient's file.
The flowchart for this program is shown in Figure 4 . The program asks for the "patient identification number" and the "drug number". After each drug number has been entered, the program automatically goes to the drug cross-reference file (XDRGNO) and replaces the pharmacy code number with the Laboratory Medicine code number. Laboratory medicine drug code numbers for additional drug numbers until all have been entered, at which time the data is stored in the PTDRG file (Table II) . The program then recycles to check for additional patients. If there are no more patients, the program checks each patient identification number against those in the patient's "laboratory summary report"(LSR) file to determine if the patient has had any tests completed and verified during the previous 24 hours. If no tests were performed on the patient, the program proceeds to the next patient until all have been checked.
If test results were verified, the test index is stored in an array and all of that patient's drug information is copied to a separate buffer (PDBUF). The interaction information for each drug in PDBUF then is copied from the DRGTST file into another buffer (INTBUF) and a check is made to determine if there is a match between tests affected by the drug and tests performed. If a match is found, the program determines the test name, the effect of the drug on the test result and the result number and uses this information to automatically construct a comment which is attached to the result. The program then checks to determine if there are any additional drugs for that patient and, if not, if there are any additional patients. The comment which is attached to the result automatically appears when the patient's data is displayed on the cathode ray tube and when'it is printed for the nursing station.
The technique by which the comment is automatically assembled and inserted into the patient's file deserves futher explanation. The laboratory computer system software already had the capability of attaching an alphanumberic comment of up to 60 characters to any test result in the patient's file.
To facilitate operation of the 'DRGINT' program, a general comment was constructed (using data statements and a buffer) with blank areas into which could be written the drug name, the test reporting name and the effect -all of which easily can be obtained from the test interaction code and the interaction file.
An example of such a comment(s) attached to a patient's result is shown in Figure 5 . Since the actual comment is stored in a 'COMENT' file rather than in the patient's data file, the latter file must contain a pointer to the appropriate index in the 'COMENT' file.
Moreover, if more than one comment is attached to a result, a pointer must be associated with each comment pointing to the next comment. The software developed writes the necessary pointers in the correct locations. When a patient's record finally is stored on archival magnetic tape, the comment(s) becomes an integral part of the record.
The program can be written such that all results are checked to determine if they are elevated or lowered by the drug in question or only those results which are abnormal can be checked. To examine every result uses additional computer time and may make the report somewhat cumbersome with comments. Conversely, some results which appear normal may actually be elevated, e.g. a normal glucose result on a hypoglycemic patient who is receiving aminosalicylic acid, which elevates the result. Until more experience is gained in the use of the system, it seems advisable to check only the abnormal results to avoid any degradation in system response time and cluttered reports.
HARDWARE AND SOFTWARE SPECIFICATIONS
The overall system on which the above programs are run has been described in detail elsewhere (8) . Briefly, however, the ~entral processing hardware is as follows: one Control Data Corporation*, model 1784, computer with 16-bit words and 256K bytes of memory; two Control Data Corporation, model 9746, disk drives each with 55 megabytes of storage.
All programs were written in Control Data Corporation FORTRAN IV. All source programs were developed using the on-line edit and compile capabilities of the system. The size of each program is as follows: MAY BE ELEVATED PERMANENT REPORT -RETAINiON CHART ********************** 
